Please login to the form below

Not currently logged in
Email:
Password:

Lonza appoints pharma COO

Marc Funk replaces Stephan Kutzer

Marc Funk LonzaSwiss life sciences firm Lonza has announced that Stephan Kutzer is to step down as chief operations officer for its pharma and biotech division to be replaced by Marc Funk.

Funk, who is currently the company's chief legal officer, will take over from Kutzer on July 1, 2014.

Richard Ridinger, CEO of Lonza, said: “[Funk] has already successfully managed operational and commercial projects in the pharma and biotech network and has been responsible for global quality in pharma & biotech for more than a year.”

Funk's experience prior to joining Lonza in 2008 includes four years as corporate counsel at Merck Serono.

He was also previously a co-CEO at GeneProt, a now defunct US-based biotech company.

29th April 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

World Heart Day 2020: It's time to make our clinical trials more inclusive
September 29th is World Heart Day, a day dedicated to raising awareness about cardiovascular diseases and how everyone can take steps to prevent them. It’s common knowledge that smoking and...
Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...

Infographics